Revenue forecast of AbbVie's Humira 2018-2024
In 2018, AbbVie's top product Humira generated nearly 20 billion U.S. dollars of revenue. Due to patent loss and biosimilars competition, it is expected that the revenue will decrease to some 13 billon dollars until 2024. Due to Abbot Laboratories was a U.S.-based global pharmaceutical and healthcare products company, headquartered in Chicago, Illinois. In January 2013, Abbott was separated into two companies: Abbott and AbbVie. Abbott is now specialized on medical products, while AbbVie is responsible for research-based pharmaceuticals.
